Skip to main content
. 2024 May 5;12(5):500. doi: 10.3390/vaccines12050500

Figure A33.

Figure A33

Sensitivity analysis on vaccine efficacy (VE) for respiratory syncytial virus (RSV) vaccines in older adults (age ≥ 70/75 years) with lower respiratory tract disease with 2 signs/symptoms [51,52,81,82].